TrialThe Lancet. Respiratory medicine2022

Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial.

Cameron R Wolfe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.